# Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients

> **NCT02707263** · NA · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** intravenous continuous infusion of heparin (IV UFH)
- **DRUG:** Subcutaneous Heparin

## Key facts

- **NCT ID:** NCT02707263
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-03
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707263, "Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02707263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*